Mantle Cell Lymphoma Care From Diagnosis Through Relapse: Expert Guidance on Applying the Latest Evidence

Explore key issues in the management of MCL in this comprehensive program designed to keep you abreast of rapidly evolving treatment strategies. Gain insights on new developments as they emerge with the interactive module downloadable slideset short expert commentaries and an Interactive Decision Support Tool that lets you compare your treatment choices for MCL patient scenarios you enter with those of 5 experts.

Share

Program Content

Activities

Optimizing Induction for MCL
My Thoughts on Optimizing Induction Therapy for MCL
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: April 30, 2018

Expires: April 29, 2019

MCL: BTK Inhibitors
MCL at First Relapse: Selecting a First- vs Second-Generation BTK Inhibitor
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: August 10, 2018

Expires: August 09, 2019

Activities

MCL: Diagnosis to Relapse
Mantle Cell Lymphoma Care From Diagnosis Through Relapse: Expert Guidance on Applying the Latest Evidence as Part of Clinical Routine
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: November 13, 2018

Expires: November 12, 2019

Faculty

cover img faculity

Stephen Ansell, MD, PhD

Associate Professor of Medicine
Department of Hematology
Mayo Clinical Cancer Center
Rochester, Minnesota

cover img faculity

Christopher R. Flowers, MD, MS

Department Chair
Department of Lymphoma/Myeloma, Division of Cancer Medicine
University of Texas MD Anderson Cancer Center
Houston, Texas

cover img faculity

Julie M. Vose, MD

Neumann M. and Mildred E. Harris Professor
Chief
, Section of Hematology/Oncology
Professor of Medicine
University of Nebraska Medical Center
Omaha, Nebraska

Provided by

ProCE Banner

Supporters

This activity is supported by educational grants from

AbbVie

AstraZeneca Pharmaceuticals

Pharmacyclics Inc